{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T05:32:33Z","timestamp":1788845553434,"version":"build-2803163510"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"attorneys representing families regarding ondansetron use in pregnancy"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive Toxicology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.reprotox.2018.08.018","type":"journal-article","created":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T13:58:27Z","timestamp":1535119107000},"page":"237-245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Ondansetron and teratogenicity in rats: Evidence for a mechanism mediated via embryonic hERG blockade"],"prefix":"10.1016","volume":"81","author":[{"given":"B.","family":"Danielsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William S.","family":"Webster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen E.","family":"Ritchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.reprotox.2018.08.018_bib0005","series-title":"Ondansetron Use in Early Pregnancy and the Risk of Congenital Malformations - a Registry Based Nationwide Cohort Study. International Society of Pharmaco-epidemiology","author":"Andersen","year":"2013"},{"key":"10.1016\/j.reprotox.2018.08.018_bib0010","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.reprotox.2014.10.017","article-title":"Use of ondansetron during pregnancy and congenital malformations in the infant","volume":"50","author":"Danielsson","year":"2014","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.reprotox.2018.08.018_bib0015","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/bdra.22865","article-title":"Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects","volume":"94","author":"Anderka","year":"2012","journal-title":"Birth Defects Res."},{"key":"10.1016\/j.reprotox.2018.08.018_bib0020","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1056\/NEJMoa1211035","article-title":"Ondansetron in pregnancy and risk of adverse fetal outcomes","volume":"368","author":"Pasternak","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.reprotox.2018.08.018_bib0025","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.reprotox.2016.04.027","article-title":"Ondansetron in pregnancy and risk of adverse fetal outcomes in the United States","volume":"62","author":"Fejzo","year":"2016","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.reprotox.2018.08.018_bib0030","series-title":"Catalog of Teratogenic Agents","author":"Shepard","year":"2010"},{"key":"10.1016\/j.reprotox.2018.08.018_bib0035","series-title":"Draft ICH Harmonised Guideline S5(R3): Detection of Toxicity to Reproduction for Human Pharmaceuticals","author":"ICH Steering Committee","year":"2017"},{"key":"10.1016\/j.reprotox.2018.08.018_bib0040","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0022-3565(24)38946-3","article-title":"Interactions of the 5-hydroxytryptamine 3 antagonist class of antiemetic drugs with human cardiac ion channels","volume":"295","author":"Kuryshev","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.reprotox.2018.08.018_bib0045","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1476-5381.1994.tb17021.x","article-title":"Block of the delayed rectifier current (IK) by the 5-HT3 antagonists ondansetron and granisetron in feline ventricular myocytes","volume":"113","author":"de Lorenzi","year":"1994","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.reprotox.2018.08.018_bib0050","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s12012-017-9403-5","article-title":"Severe proarrhythmic potential of the antiemetic agents ondansetron and domperidone","volume":"17","author":"Frommeyer","year":"2017","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.reprotox.2018.08.018_bib0055","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1472-8206.2009.00735.x","article-title":"Droperidol and ondansetron in vitro electrophysiological drug interaction study","volume":"23","author":"Weissenburger","year":"2009","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.reprotox.2018.08.018_bib0060","first-page":"100","article-title":"Drug-induced spatial dispersion of repolarization","volume":"15","author":"Antzelevitch","year":"2008","journal-title":"Cardiol. J."},{"key":"10.1016\/j.reprotox.2018.08.018_bib0065","series-title":"Credible Meds - Available TdP Risk Categories","first-page":"218","author":"Arizona Center for Education on Research on Therapeutics","year":"2018"},{"key":"10.1016\/j.reprotox.2018.08.018_bib0070","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/PEC.0000000000000317","article-title":"Fatal cardiac arrest in 2 children: possible role of ondansetron","volume":"32","author":"Brenner","year":"2016","journal-title":"Pediatr. Emerg. Care"},{"key":"10.1016\/j.reprotox.2018.08.018_bib0075","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.annemergmed.2013.10.026","article-title":"Ondansetron and the risk of cardiac arrhythmias: a systematic review and postmarketing analysis","volume":"64","author":"Freedman","year":"2014","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.reprotox.2018.08.018_bib0080","doi-asserted-by":"crossref","first-page":"366","DOI":"10.14503\/THIJ-16-6040","article-title":"Torsades de Pointes after Ondansetron infusion in two patients","volume":"44","author":"Lee","year":"2017","journal-title":"Tex. Heart Inst. J."},{"key":"10.1016\/j.reprotox.2018.08.018_bib0085","series-title":"Drug Safety Communication: Abnormal Heart Rhythms May Be Associated With Use of Zofran (ondansetron)","author":"FDA","year":"2011"},{"key":"10.1016\/j.reprotox.2018.08.018_bib0090","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/cvr\/cvs296","article-title":"Exploration of human, rat, and rabbit embryonic cardiomyocytes suggests K-channel block as a common teratogenic mechanism","volume":"97","author":"Danielsson","year":"2013","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.reprotox.2018.08.018_bib0095","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1034\/j.1600-0773.2001.088001034.x","article-title":"Developmental toxicity in the pregnant rabbit by the class III antiarrhythmic drug sotalol","volume":"88","author":"Skold","year":"2001","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.reprotox.2018.08.018_bib0100","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.reprotox.2007.04.005","article-title":"Embryonic cardiac arrhythmia and generation of reactive oxygen species: common teratogenic mechanism for IKr blocking drugs","volume":"24","author":"Danielsson","year":"2007","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.reprotox.2018.08.018_bib0105","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/(SICI)1096-9926(199603)53:3<168::AID-TERA4>3.0.CO;2-0","article-title":"Teratogenic potential of almokalant, dofetilide, and d-sotalol: drugs with potassium channel blocking activity","volume":"53","author":"Webster","year":"1996","journal-title":"Teratology"},{"key":"10.1016\/j.reprotox.2018.08.018_bib0110","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0890-6238(02)00042-4","article-title":"Teratogenicity of the I(Kr)-blocker cisapride: relation to embryonic cardiac arrhythmia","volume":"16","author":"Skold","year":"2002","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.reprotox.2018.08.018_bib0115","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/bdrb.21162","article-title":"The effect of dofetilide on the heart rate of GD11 and GD13 rat embryos, in vivo","volume":"104","author":"Ritchie","year":"2015","journal-title":"Using Ultrasound. Birth Defects Res. B"},{"key":"10.1016\/j.reprotox.2018.08.018_bib0120","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/tera.1084","article-title":"Stage-specific skeletal and visceral defects of the I(Kr)-blocker almokalant: further evidence for teratogenicity via a hypoxia-related mechanism","volume":"64","author":"Skold","year":"2001","journal-title":"Teratology"},{"key":"10.1016\/j.reprotox.2018.08.018_bib0125","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.00641.2016","article-title":"Blood flow patterns underlie developmental heart defects","volume":"312","author":"Midgett","year":"2017","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.reprotox.2018.08.018_bib0130","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/tera.1420210305","article-title":"Role of decreased cardiac output in isoproterenol-induced cardiovascular teratogenesis in chick embryos","volume":"21","author":"Gilbert","year":"1980","journal-title":"Teratology"},{"key":"10.1016\/j.reprotox.2018.08.018_bib0135","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s10237-012-0414-7","article-title":"Biomechanics of early cardiac development","volume":"11","author":"Goenezen","year":"2012","journal-title":"Biomech. Model. Mechanobiol."},{"key":"10.1016\/j.reprotox.2018.08.018_bib0140","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/tera.1420300311","article-title":"The role of dysrhythmic heart function during cardiovascular teratogenesis in epinephrine-treated chick embryos","volume":"30","author":"Rajala","year":"1984","journal-title":"Teratology"},{"key":"10.1016\/j.reprotox.2018.08.018_bib0145","doi-asserted-by":"crossref","DOI":"10.1002\/bdr2.1136","article-title":"Early gestational hypoxia and adverse developmental outcomes","volume":"109","author":"Ritchie","year":"2017","journal-title":"Birth Defects Res."},{"key":"10.1016\/j.reprotox.2018.08.018_bib0150","first-page":"s1165","article-title":"Study of administration of ondansetron hydrochloride via oral route to rats during the fetal organogenesis period","volume":"20","author":"Shimizu","year":"1992","journal-title":"Yakuri to Chiryo"},{"key":"10.1016\/j.reprotox.2018.08.018_bib0155","first-page":"s1145","article-title":"Study of administration of ondansetron hydrochloride to rats by the intravenous route during the fetal organogenesis period","volume":"20","author":"Shimizu","year":"1992","journal-title":"Yakuri to Chiryo"},{"key":"10.1016\/j.reprotox.2018.08.018_bib0160","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0002-9149(70)90575-8","article-title":"Developmental landmarks in cardiac morphogenesis: comparative chronology","volume":"25","author":"Sissman","year":"1970","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.reprotox.2018.08.018_bib0165","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1148\/radiol.2362040880","article-title":"Outcome of first-trimester pregnancies with slow embryonic heart rate at 6-7 weeks gestation and normal heart rate by 8 weeks at US","volume":"236","author":"Doubilet","year":"2005","journal-title":"Radiology"},{"key":"10.1016\/j.reprotox.2018.08.018_bib0170","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/bdrb.20270","article-title":"The effect of drugs with ion channel-blocking activity on the early embryonic rat heart","volume":"89","author":"Abela","year":"2010","journal-title":"Birth Defects Res. B Dev. Reprod. Toxicol."},{"key":"10.1016\/j.reprotox.2018.08.018_bib0175","series-title":"Advances in Mass Data Analysis of Images and Signals in Medicine, Biotechnology, Chemistry and Food Industry","first-page":"27","article-title":"Fully automatic heart beat rate determination in digital video recordings of rat embryos","author":"Khan","year":"2008"},{"key":"10.1016\/j.reprotox.2018.08.018_bib0180","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2165\/00003088-199529020-00004","article-title":"Ondansetron clinical pharmacokinetics","volume":"29","author":"Roila","year":"1995","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.reprotox.2018.08.018_bib0185","first-page":"11","article-title":"Clinical pharmacology of ondansetron in postoperative nausea and vomiting","volume":"6","author":"Baber","year":"1992","journal-title":"Eur. J. Anaesthesiol. Suppl."},{"issue":"25 Suppl 1","key":"10.1016\/j.reprotox.2018.08.018_bib0190","first-page":"S21","article-title":"The clinical pharmacology of ondansetron","author":"Blackwell","year":"1989","journal-title":"Eur. J. Cancer Clin. Oncol."},{"issue":"Suppl. 10","key":"10.1016\/j.reprotox.2018.08.018_bib0195","article-title":"A dose-proportionality study of ondansetron administered as a single oral dose (tablet) to healthy male volunteers","author":"Haberer","year":"1993","journal-title":"Pharm. Res."},{"key":"10.1016\/j.reprotox.2018.08.018_bib0200","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1002\/phar.1796","article-title":"Ondansetron exposure changes in a pregnant woman","volume":"36","author":"Lemon","year":"2016","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.reprotox.2018.08.018_bib0205","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/cpt.5","article-title":"Ondansetron pharmacokinetics in pregnant women and neonates: towards a new treatment for neonatal abstinence syndrome","volume":"97","author":"Elkomy","year":"2015","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.reprotox.2018.08.018_bib0210","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2165\/00003088-200645040-00006","article-title":"Placental transfer of ondansetron during early human pregnancy","volume":"45","author":"Siu","year":"2006","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.reprotox.2018.08.018_bib0215","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/bdd.628","article-title":"Dose-independent pharmacokinetics of ondansetron in rats: contribution of hepatic and intestinal first-pass effects to low bioavailability","volume":"29","author":"Yang","year":"2008","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.reprotox.2018.08.018_bib0220","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1365-2125.1993.tb04164.x","article-title":"The pharmacokinetics of intravenous ondansetron in patients with hepatic impairment","volume":"35","author":"Blake","year":"1993","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.reprotox.2018.08.018_bib0225","series-title":"Zofran (ondansetron Hydrchloride) Injection. PHarmacologists Review 1990","first-page":"p49","author":"FDA.NDA","year":"2007"},{"key":"10.1016\/j.reprotox.2018.08.018_bib0230","series-title":"Historical Control Data for Development and Reproductive Toxicity Studies Using the CrI:CD\u00ae BR Rat","author":"MARTA Middle Atlantic Reproduction and Teratology Association","year":"1993"},{"key":"10.1016\/j.reprotox.2018.08.018_bib0235","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/(SICI)1096-9926(199609)54:3<157::AID-TERA6>3.0.CO;2-0","article-title":"Developmental toxicity of ibutilide fumarate in rats after oral administration","volume":"54","author":"Marks","year":"1996","journal-title":"Teratology"},{"key":"10.1016\/j.reprotox.2018.08.018_bib0240","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/bdd.627","article-title":"Gender differences in ondansetron pharmacokinetics in rats","volume":"29","author":"Yang","year":"2008","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.reprotox.2018.08.018_bib0245","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/clpt.1992.7","article-title":"Age and gender effects on ondansetron pharmacokinetics: evaluation of healthy aged volunteers","volume":"51","author":"Frederick","year":"1992","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.reprotox.2018.08.018_bib0250","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s13318-011-0053-x","article-title":"Preclinical evaluation of drug in adhesive type ondansetron loaded transdermal therapeutic systems","volume":"36","author":"Swain","year":"2011","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.reprotox.2018.08.018_bib0255","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.pbiomolbio.2016.05.002","article-title":"Rabbit models as tools for preclinical cardiac electrophysiological safety testing: importance of repolarization reserve","volume":"121","author":"Baczko","year":"2016","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"10.1016\/j.reprotox.2018.08.018_bib0260","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1111\/j.1540-8167.2006.00637.x","article-title":"Arrhythmogenesis in the developing heart during anoxia-reoxygenation and hypothermia-rewarming: an in vitro model","volume":"17","author":"Sarre","year":"2006","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.reprotox.2018.08.018_bib0265","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1111\/j.1540-8167.2006.00641.x","article-title":"A beat is born: embryonic development of arrhythmogenesis","volume":"17","author":"Berul","year":"2006","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.reprotox.2018.08.018_bib0270","doi-asserted-by":"crossref","first-page":"R379","DOI":"10.1152\/ajpregu.00534.2001","article-title":"Developmental changes in cardiac recovery from anoxia-reoxygenation","volume":"283","author":"Sedmera","year":"2002","journal-title":"Am. J. Physiol. \u2013 Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.reprotox.2018.08.018_bib0275","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/01.mjt.0000143698.53038.1b","article-title":"A mechanism for the potential proarrhythmic effect of acidosis, bradycardia, and hypokalemia on the blockade of human ether-a-go-go-related gene (HERG) channels","volume":"12","author":"Lin","year":"2005","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.reprotox.2018.08.018_bib0280","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.reprotox.2010.01.014","article-title":"Improved methodology for identifying the teratogenic potential in early drug development of hERG channel blocking drugs","volume":"29","author":"Nilsson","year":"2010","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.reprotox.2018.08.018_bib0285","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/bdrb.21003","article-title":"Antidepressants cause bradycardia and heart block in GD 13 rat embryos in vitro","volume":"95","author":"Ababneh","year":"2012","journal-title":"Birth Defects Res. B Dev. Reprod. Toxicol."},{"key":"10.1016\/j.reprotox.2018.08.018_bib0290","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2016.00592","article-title":"Dynamic expression of serotonin receptor 5-HT3A in developing sensory innervation of the lower urinary tract","volume":"10","author":"Ritter","year":"2017","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.reprotox.2018.08.018_bib0295","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1523\/JNEUROSCI.22-03-01010.2002","article-title":"The 5-HT3 subtype of serotonin receptor contributes to nociceptive processing via a novel subset of myelinated and unmyelinated nociceptors","volume":"22","author":"Zeitz","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.reprotox.2018.08.018_bib0300","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.108.177055","article-title":"Homozygous missense N629D hERG (KCNH2) potassium channel mutation causes developmental defects in the right ventricle and its outflow tract and embryonic lethality","volume":"103","author":"Teng","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.reprotox.2018.08.018_bib0305","first-page":"641","article-title":"Autosomal dominant mendelian midline complex, secundum atrial septal defect associated to cardiac and facio-thoracic defects. A familial case","volume":"93","author":"Stephan","year":"2000","journal-title":"Arch. Mal. Coeur Vaiss."},{"key":"10.1016\/j.reprotox.2018.08.018_bib0310","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1136\/hrt.82.3.386","article-title":"A variant of long QT syndrome manifested as fetal tachycardia and associated with ventricular septal defect","volume":"82","author":"Wu","year":"1999","journal-title":"Heart"},{"key":"10.1016\/j.reprotox.2018.08.018_bib0315","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00246-004-0712-7","article-title":"Post-hoc diagnosis of congenital long QT syndrome in patients with tetralogy of Fallot","volume":"26","author":"Walls","year":"2005","journal-title":"Pediatr. Cardiol."},{"key":"10.1016\/j.reprotox.2018.08.018_bib0320","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1017\/S1047951105000648","article-title":"A case of long QT syndrome associated with familial occurrence of persistent patency of the arterial duct","volume":"15","author":"Murugan","year":"2005","journal-title":"Cardiol. Young"},{"key":"10.1016\/j.reprotox.2018.08.018_bib0325","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/cvr\/28.3.337","article-title":"Induction of rhythm abnormalities in the fetal rat heart. A tentative mechanism for the embryotoxic effect of the class III antiarrhythmic agent almokalant","volume":"28","author":"Abrahamsson","year":"1994","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.reprotox.2018.08.018_bib0330","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2016-217158","article-title":"ECG changes in hyperemesis gravidarum","volume":"2017","author":"Mitchell","year":"2017","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.reprotox.2018.08.018_bib0335","first-page":"81","article-title":"Ondansetron-induced life threatening hypokalemia","volume":"64","author":"Mathew","year":"2016","journal-title":"J. Assoc. Phys. India"},{"key":"10.1016\/j.reprotox.2018.08.018_bib0340","article-title":"Assessment of ondansetron-associated hypokalemia in pediatric oncology patients","volume":"2012","author":"Fiedrich","year":"2012","journal-title":"ISRN Oncol."},{"key":"10.1016\/j.reprotox.2018.08.018_bib0345","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/toxsci\/kfx225","article-title":"Editor\u2019s Highlight: Ethylene Glycol Teratogenicity: A Role for Embryonic Acidosis?","volume":"161","author":"Ritchie","year":"2018","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.reprotox.2018.08.018_bib0350","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1476-5381.2011.01367.x","article-title":"Cardiac ventricular repolarization reserve: a principle for understanding drug-related proarrhythmic risk","volume":"164","author":"Varro","year":"2011","journal-title":"Br. J. Pharmacol."}],"container-title":["Reproductive Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623818300972?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623818300972?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:52:45Z","timestamp":1760190765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890623818300972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":70,"alternative-id":["S0890623818300972"],"URL":"https:\/\/doi.org\/10.1016\/j.reprotox.2018.08.018","relation":{},"ISSN":["0890-6238"],"issn-type":[{"value":"0890-6238","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ondansetron and teratogenicity in rats: Evidence for a mechanism mediated via embryonic hERG blockade","name":"articletitle","label":"Article Title"},{"value":"Reproductive Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reprotox.2018.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}